FIGURE

Fig. 3

ID

ZDB-FIG-240508-39

Publication

Zhao et al., 2023 - Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Melanocyte deficiency in vitiligo lesions is accompanied by impaired expression of PPAR-γ and EDNRB. a Representative images of the melanocytes in healthy skin samples (n = 5) and vitiligo lesions (n = 5) detected by immunofluorescence. Melanocytes were stained with antibodies to TYR (green) and MITF (red). Nuclei were counterstained with DAPI (blue). b Representative images of the expression of PPAR-γ (green) in healthy skin (n = 5) and vitiligo lesions (n = 5) detected using immunofluorescence. Melanocytes were stained with antibodies to MITF (red). Nuclei were counterstained with DAPI (blue). c Representative images of the expression of EDNRB (green) in healthy skin (n = 5) and vitiligo lesions (n = 5) detected using immunofluorescence. Melanocytes were stained with antibodies to MITF (red). Nuclei were counterstained with DAPI (blue).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Inflammation